Home » Stocks » Brainsway

Brainsway Ltd. (BWAY)

Stock Price: $5.55 USD 0.03 (0.54%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 61.75M
Revenue (ttm) 22.08M
Net Income (ttm) -10.33M
Shares Out 11.13M
EPS (ttm) -1.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $5.55
Previous Close $5.52
Change ($) 0.03
Change (%) 0.54%
Day's Open 5.55
Day's Range 5.50 - 5.71
Day's Volume 9,397
52-Week Range 5.10 - 12.53

More Stats

Market Cap 61.75M
Enterprise Value 39.85M
Earnings Date (est) Aug 31, 2020
Ex-Dividend Date n/a
Shares Outstanding 11.13M
Float 3.65M
EPS (basic) -1
EPS (diluted) -1.08
FCF / Share -0.98
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 11,051
Short Ratio 1.47
Short % of Float n/a
Beta 0.63
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.80
PB Ratio 3.19
Revenue 22.08M
Operating Income -8.48M
Net Income -10.33M
Free Cash Flow -10.56M
Net Cash 21.90M
Net Cash / Share 1.97
Gross Margin 86.80%
Operating Margin -38.39%
Profit Margin -44.70%
FCF Margin -47.81%
ROA -19.59%
ROE -89.56%
ROIC -87.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(110.45% upside)
Current: 5.55
Target: 11.68
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth40.89%47.12%-
Gross Profit17.9712.818.55
Operating Income-8.48-5.11-6.61
Net Income-10.33-6.48-7.05
Shares Outstanding21.6421.64-
Earnings Per Share-1.00-0.78-0.96
Operating Cash Flow-7.24-3.77-3.47
Capital Expenditures-3.31-1.97-0.99
Free Cash Flow-10.56-5.75-4.45
Cash & Equivalents21.909.0714.56
Total Debt-2.832.73
Net Cash / Debt21.906.2411.83
Book Value24.226.9512.72
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Brainsway Ltd.
Country Israel
Employees 107
CEO Christopher von Jako

Stock Information

Ticker Symbol BWAY
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BWAY
IPO Date October 6, 1999


Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel.